Skip to main content
. 2021 Jan 16;9(1):83. doi: 10.3390/biomedicines9010083
SLE systemic lupus erythematosus
T1D type 1 diabetes
MS multiple sclerosis
RA rheumatoid arthritis
BCR B cell receptor
tNPs tolerogenic nanoparticles
APC antigen-presenting cell
MHC major histocompatibility complex
EAE experimental autoimmune encephalomyelitis
FVIII Factor VIII
CAR chimeric antigen receptor
ITAM immunoreceptor tyrosine-based activation motif
PV pemphigus vulgaris
Dsg3 desmoglein 3
NOD non-obese diabetic
BAR B-cell-targeting Antibody Receptor
CAAR chimeric auto-antibody receptor
Treg T regulatory cell
Teff T effector cell
NK natural killer cell
ADCC antibody-dependent cell-mediated cytotoxicity
ADC antibody-drug conjugate